triple-negative breast cancer
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
triple-negative breast cancer
Jul 24, 2024, 00:59 |
Insight
Luca Licata: The fate of immunotherapy trials in breast cancer
Marco Mariani, Resident in Medical Oncology at San Raffaele Scientific Institute, shared a post on X…
Jul 22, 2024, 23:09 |
Blog
Aleix Prat: TNBC-DX - new genomic profiling tool for the treatment of early-stage triple-negative breast cancer (TNBC)
Aleix Prat, Director of Cancer Institute and Blood Disorders at Clinical Hospital of Barcelona, shared…
Jul 10, 2024, 05:38 |
Blog
Marleen Kok: My team will be awarded grant of 4.1 million euro from KWF Dutch Cancer Society
Marleen Kok, Associate Professor at The Netherlands Cancer Institute, shared a post on X: "Incredibly…
Jun 29, 2024, 23:21 |
Insight
Andrea Morandi: A critical vulnerability in triple-negative breast cancer
Andrea Morandi, Professor at University of Florence, shared on LinkedIn: "I'm thrilled to share our…
Jun 29, 2024, 03:18 |
Blog
Peter Schmid's findings on atezolizumab and sacituzumab govitecan for advanced TNBC - ESMO
ESMO shared a post on LinkedIn: “For ESMO members: Breaking Science in Breast Cancer. Peter Schmid…
Jun 27, 2024, 13:27 |
Blog
Douglas Flora: MRD AI tests are proving to be invaluable tools in our decision-making process
Douglas Flora shared a post on LinkedIn: “As I’ve been working my way through the latest…
Jun 27, 2024, 07:17 |
Blog
Thomas R. Cox: Future Leaders in Metastasis Research
Thomas R. Cox, Laboratory Head of Matrix and Metastasis, shared on X: "All the way from…
Jun 26, 2024, 03:41 |
Insight
Paolo Tarantino: Opportunities to improve outcomes for early recurrent TNBC
Paolo Tarantino shared a post on X: . "Early recurrent TNBC (Triple-Negative…
Jun 15, 2024, 13:17 |
Blog
Amy Gittelman: Incredibly Creative Way to Raise Funds for Breast Cancer Research
Amy Gittelman, Area Vice President at Veradigm, made the following post on LinkedIn: "Incredibly creative…
Jun 10, 2024, 07:06 |
Blog
Sherene Loi spoke with Sadia Zapp global collaboration and strategies to better treat younger patients - BCRF
Quoting The Breast Cancer Research Foundation on LinkedIn: "BCRF investigator Dr. Sherene Loi spoke with…
Jun 6, 2024, 12:16 |
Dialogues
ASCO24 Updates: A Multi-Ancestry Polygenic Risk Score Helps to Predict Triple-Negative Breast Cancer
The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…
Jun 4, 2024, 16:28 |
Societies
Erika Hamilton: Data that pCR translates to outcome in TNBC
Erika Hamilton shared a post on X: “PEARLY: Adriamycin Cyclophosphamide (AC) to Taxane versus AC…
Jun 2, 2024, 23:43 |
Societies
Jeliazko Arabadjiev: It was an immense honor and pleasure to listen to Jennifer Pietenpol’s lecture
Jeliazko Arabadjiev, President of the Bulgarian Scientific Society of Immuno-Oncology, recently shared on LinkedIn: "Prof.…
Jun 1, 2024, 12:11 |
Societies
Carlos Torrado: Excited to present our poster at ASCO24
Carlos Torrado, Clinical Fellow at MD Anderson Cancer Center, recently shared a post by NCI…
May 21, 2024, 15:41 |
Insight
Yakup Ergün: A valuable retrospective study on PD-L1 alteration after NAC in TNBC
Yakup Ergün, Medical Oncologist at Ankara Numune Training and Research Hospital, shared a post on…
May 18, 2024, 10:02 |
Societies
Matteo Lambertini: What a big honor to have Sara Tolaney at our ESMOYOC session
Matteo Lambertini, Medical Oncologist at San Martino, shared on X: . "What a big honor…
Apr 25, 2024, 21:06 |
Drugs
Piotr Wysocki: Datopotamab deruxtecan – another anti-TROP2 conjugate demonstrating activity in advanced ER+/HER2- and triple-negative breast cancer patients
Piotr Wysocki recently shared on LinkedIn: "Datopotamab deruxtecan – a novel anti-TROP2 conjugate demonstrates activity…
Apr 23, 2024, 20:00 |
Blog
,
Insight
Sendurai Mani: Visionary Leadership in Action
Sendurai Mani, Dean’s Chair of Translational Oncology at Brown University and Founder and Advisor at Iylon Precision…
Apr 20, 2024, 20:17 |
Insight
Paolo Tarantino: Tumor-infiltrating lymphocytes (TILs): not only prognostic in Triple-Negative Breast Cancer
Paolo Tarantino, Research fellow at Dana Farber Cancer Institute, shared on X: "Tumor-infiltrating lymphocytes (TILs): not…
Apr 15, 2024, 14:01 |
Insight
New Paper Alert! How Tumor Biomechanics Shape Metastatic Dissemination of Triple Negative Breast Cancer
How Tumor Biomechanics Shape Metastatic Dissemination of Triple Negative Breast Cancer Authors: Elysse C. Filipe,*…
Apr 12, 2024, 05:34 |
Insight
Joe Lennerz: Quickly sharing a fantastic paper on tumour infiltrating lymphocytes in triple-negative breast cancer
Joe Lennerz, Chief Scientific Officer at BostonGene, shared on LinkedIn: "Quickly sharing a fantastic paper…
Dec 21, 2023, 10:12 |
Career
Congratulations to Dr. Marilena Tauro on receiving the NCI/NIH R03 grant - Moffitt Cancer Center
Moffitt Cancer Center shared on LinkedIn: "Congratulations to Dr. Marilena Tauro on receiving the NCI/NIH…
Dec 9, 2023, 16:34 |
Blog
Gustavo Werutsky: Excited to share the TROPION-Breast04 international study poster from SABCS 2023
Gustavo Werutsky, Medical Oncologist of the Breast Cancer Program at the Moinhos de Vento Hospital,…
Dec 8, 2023, 17:50 |
Drugs
Pure Biologics to test molecule PBA-0405 in project PB004 in a Phase 0 clinical trial in patients with solid tumors - The Antibody Society
The Antibody Society shared on their LinkedIn page: "In an unusual (to us anyway) move,…
All:
24
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube